Project Details
| Short title | TLN-121-2501 |
|---|---|
| Status | Active |
| Effective start/end date | 28/07/25 → 22/05/26 |
CTU: An Open-Label, Multicenter, Phase 1 Trial to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of TLN-121 as a Single Agent, and in Combination with Other Antilymphoma Agents, in Patients with Relapsed or Refractory Non-Hodgkin Lymphomas
- Menzies Wojtowicz, Monique (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- Delahunt Smoleniec, Jacqui (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
- Lawrie, Angus (Clinical Trial Unit Staff)
Project: Research